Targeted philanthropic interventions are increasingly reshaping how distress is addressed within the United States healthcare system. According to financial reporting compiled by Fortune, billionaire philanthropist MacKenzie Scott has provided more than $100 million in direct funding to Undue Medical Debt—formerly known as RIP Medical Debt—enabling the non-profit organization to purchase and forgive more than $40 billion in outstanding patient bills across all 50 states.
Scott, who acquired a 4% stake in Amazon following her divorce from founder Jeff Bezos, has progressively liquidated portions of her holdings to fund widespread charitable causes. With an estimated net worth of $33.8 billion, her total lifetime contributions have surpassed $26 billion distributed among more than 2,500 organizations, including historically Black colleges and universities, environmental programs, and economic justice initiatives. Her focused capital injections into medical debt purchasing have transformed a modest non-profit operation into a major national economic safety valve.
The Debt Arbitrage Mechanism
The operational framework utilized by Undue Medical Debt leverages systemic inefficiencies in secondary financial markets. When healthcare providers, including hospitals and physician networks, determine that unpaid patient accounts are uncollectible, they frequently bundle these liabilities into large portfolios and sell them to third-party collection agencies at steep discounts.
Rather than allowing commercial collectors to acquire these accounts to pursue active recovery, Undue Medical Debt acts as a non-profit buyer. Utilizing donor funds, the organization acquires these distressed debt portfolios for pennies on the dollar. Because the non-profit purchases the obligations outright with no intention of collection, it immediately cancels the liabilities without creating tax burdens or credit penalties for the affected individuals. The effective financial ratio allows every $10 in charitable contributions to extinguish approximately $1,000 in nominal healthcare debt. In April 2025, the group executed its largest single transaction to date, acquiring and retiring a $30 billion debt portfolio that effectively wiped out obligations for roughly 20 million citizens.
Replication by Private Donors and Local Governments
The scale of Scott’s financial backing has accelerated broader adoption of secondary debt relief by private donors, philanthropic foundations, and municipal authorities. Snap co-founder Evan Spiegel and his spouse, Miranda Kerr, subsequently directed millions in funding to the organization, resulting in the cancellation of $550 million in medical bills for 261,000 residents in California. Similarly, hedge fund executive Daniel Och’s family foundation provided funding to eliminate $264 million in medical debt in Miami-Dade County, Florida.
Beyond private philanthropy, local governments have incorporated the mechanism into public policy execution. Municipalities including New York City and Cook County, Illinois, allocated public funds to buy back and cancel hundreds of millions of dollars in outstanding medical obligations incurred by low-income residents, using secondary market dynamics to maximize public health equity budgets.
Regulatory Setbacks and Policy Limits
Despite the expanding volume of cancelled debt, public policy experts emphasize that voluntary market interventions remain a secondary treatment rather than a structural cure for systemic healthcare affordability issues. The total $40 billion in relief facilitated through Scott’s contributions addresses only a small segment of the cumulative medical debt carried by American households.
Furthermore, broader regulatory avenues face persistent legal opposition. On July 11, 2025, U.S. District Judge Sean Jordan of the Eastern District of Texas vacated a Consumer Financial Protection Bureau (CFPB) rule intended to remove medical debt records from consumer credit reports for an estimated 15 million individuals. The court determined that the federal regulatory agency had exceeded its statutory authority under the Fair Credit Reporting Act. With federal legislation regarding healthcare price transparency and debt forgiveness stalled in Congress, the sustainability of secondary relief depends on the continuous availability of steep market discounts and persistent private capital.